Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: Comparison of membrane integrity and drug release

European Journal of Pharmaceutical Sciences

Volumn 13, Issue 3, 2001, Pages 287-296

  Fatouros, D G ^a   Hatzidimitriou, K ^a   Antimisiaris, S G ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Cyclodextrin; Drug entrapment; Liposomal stability; Liposome; Prednisolone cyclodextrin inclusion complex

Indexed keywords

BIOLOGICAL MEMBRANES; COMPLEXATION; DEHYDRATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; LIPIDS; X RAY DIFFRACTION ANALYSIS;

LIPOSOMES;

DRUG PRODUCTS;

6 CARBOXYFLUORESCEIN; BETA CYCLODEXTRIN; CHOLESTEROL; HYDROPROPYL BETA CYCLODEXTRIN; LIPOSOME; PREDNISOLONE; PREDNISOLONE PLUS CYCLODEXTRIN; UNCLASSIFIED DRUG;

ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DISTRIBUTION; DRUG RELEASE; DRUG RETENTION; DRUG STABILITY; FOURIER ANALYSIS; LIPID COMPOSITION; LIPID MEMBRANE; LIPID METABOLISM; PRIORITY JOURNAL; SOLVATION;

ANTI-INFLAMMATORY AGENTS; BUFFERS; CALORIMETRY, DIFFERENTIAL SCANNING; CYCLODEXTRINS; DRUG CARRIERS; DRUG COMPOUNDING; LIPOSOMES; MEMBRANES, ARTIFICIAL; PARTICLE SIZE; PREDNISOLONE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 0034994593     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(01)00114-2     Document Type: Article

References (28)

1. Improvement in biopharmaceutics of prednisolone by β- and γ-cyclodextrins
2. Effects of β- and γ-cyclodextrins on the pharmacokinetic behavior of prednisolone after intravenous and intramuscular administrations to rabbits
3. Effect of the complexation of some non-steroidal anti-inflammatory drugs with β-cyclodextrin on the interaction with phosphatidylcholine liposomes
4. Serum induced leakage of liposome contents
5. Mechanism of a-cyclodextrin induced hemolysis. 2. A study of the factors controlling the association with serine-, ethanolamine- and choline phospholipids
6. Physicochemical properties of liposomes incorporating hydrochlorothiazide and chlorothiazide
7. Mechanism of α-cyclodextrin induced hemolysis. 1. The two-step extraction of phosphatidylinositol from the membrane
8. Inclusion compounds
9. Dissolution behaviour of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone
10. The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection into mice
11. Dehydration-rehydration vesicles (DRV): A new method for high yield drug entrapment in liposomes
12. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: Effect of lipid composition
13. Pharmaceutical application of cyclodextrins. 1. Drug solubilization and stability
14. Drugs-in-cyclodextrins-in-liposomes: A novel concept in drug delivery
15. Entrapment of cyclodextrin-drug complexes into liposomes: Potential advantages in drug delivery
16. Comparative studies of the fate of free and liposome-entrapped hydropropyl-β-cyclodextrin-drug complexes after intravenous injection into rats: Implications in drug delivery
17. Interactions of cyclodextrins with DPPC liposomes. Differential scanning calorimetry studies
18. Interactions of cyclodextrins with dipalmitoyl, distearoyl and dimyristoyl phosphatidyl choline liposomes. A study by leakage of carboxyfluorescein in inner aqueous phase of unilamellar liposomes
19. Cyclodextrin inclusion compounds in research and industry
20. Stability of small unilamellar liposomes in serum and clearance from the circulation: The effect of the phospholipid and cholesterol components
21. Colorimetric determination of phospholipids with ammonium ferrothiocyanate
22. Long circulating emulsion carrier systems for highly lipophilic drugs
23. Inclusion complexations of steroid hormones with cyclodextrins in water and solid phase
24. Different mode of prednisolone within α-, β-, and γ-cyclodextrins in aqueous solution in solid state
25. Improvement of oral bioavailability of prednisolone by β-cyclodextrin complexation in humans
26. Cyclodextrins in drug carrier systems
27. A comparison of the molecular structure of six corticosteroids